Delivery Order HHSN261201600015I-HHSN26100002
Award Date
7/27/16
Potential Completion Date
3/31/18
Potential Value
$632K
Federal Agency
National Cancer Institute
Awardee
IIT Research Institute
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $159,319,089.46 contract, which does not have a set-aside designation, is for preclinical toxicology and pharmacology studies to support Investigational New Drug (IND) applications for small molecule, biologic, and RNA therapeutic candidates across various...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to IIT Research Institute, a non-profit research organization, for a series of toxicology studies in rabbits for drugs developed for cancer patients. The $487,537.00 contract is part of the Toxicology of Drugs Developed for Cancer Patients indefinite delivery/indefinite quantity contract vehicle and includes dose range finding, preliminary embryo fetal...
This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
This federal contract award is for $2,708.00 to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), to provide contract orientation and kickoff meeting services for R&D under the "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications" program. The contract is being issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. IITRI...
The National Cancer Institute (NCI) awarded a $1,886,133.00 delivery order contract to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract is for toxicology studies in rats and dogs administered the compound AIT-102. The award is not associated with a set-aside designation. IITRI is a contract research organization that specializes in preclinical drug development services, including pharmacology, toxicology, safety, and efficacy...
This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $119,495.00 firm fixed-price Purchase Order is for a 14-day dose range finding study in mice to support Investigational New Drug (IND) applications. IITRI has extensive experience conducting preclinical drug development services, including toxicology,...
This is a $9,353,817.00 Cost Plus Fixed Fee contract awarded to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), by the National Cancer Institute (NCI) for preclinical toxicology services related to the development of cancer and other therapeutic large molecule drugs. The contract has no set-aside designation. IITRI is an experienced preclinical contract research organization that regularly supports the drug development efforts of federal...
This is a $2,567,101.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to IIT Research Institute, a non-profit division of Illinois Institute of Technology. The contract is for preclinical drug testing services, including pharmacology, toxicology, and safety evaluations, to support Investigational New Drug applications across therapeutic areas such as cancer, neurology, and neglected diseases. The...